3,3-bis(4-methoxyphenyl)-N-phenylacrylamide | 102592-63-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3,3-bis(4-methoxyphenyl)-N-phenylacrylamide
• 英文别名: 3,3-Di-(4-methoxyphenyl)-acrylsaeure-anilid；3,3-bis-(4-methoxy-phenyl)-acrylic acid anilide；3,3-Bis-(4-methoxy-phenyl)-acrylsaeure-anilid；N-phenyl-3,3-bis(4-methoxyphenyl)acrylamide；3,3-bis-(p-methoxyphenyl)acrylanilide；3,3-bis(4-methoxyphenyl)-N-phenylprop-2-enamide
• CAS: 102592-63-2
• 化学式: C₂₃H₂₁NO₃
• 分子量: 359.425
• InChiKey: SNMOGEBGTDCJLI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  27
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  47.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3,3-bis(4-methoxyphenyl)-N-phenylacrylamide 在 bis[3,5-difluoro-2-[5-(trifluoromethyl)-2-pyridyl]phenyl]iridium(1+); 2-(2-pyridyl)pyridine; hexafluorophosphate 、 tributylmethylammonium dibutyl phosphate 作用下， 以 1,2-二氯乙烷 为溶剂， 以77%的产率得到7-methoxy-4-(4-methoxyphenyl)-1-phenylquinolin-2(1H)-one
  参考文献：
  名称：

  Visible-Light-Photocatalyzed Synthesis of Phenanthridinones and Quinolinones via Direct Oxidative C–H Amidation

  摘要：

  A straightforward synthetic strategy to construct biologically relevant phenanthridinones and quinolinones was developed via visible-light-promoted direct oxidative C-H amidation. In this photocatalytic system, amidyl radicals can be generated by homolysis of the N-H bond of simple amide precursors via single-electron transfer under blue LED illumination, which leads to oxidative intramolecular C-H amidation. Moreover, an efficient synthetic strategy using a photocascade enabled facile assembly of quinolinone structures through a catalytic sequence involving triplet energy (E-T) transfer based E/Z olefin isomerization and subsequent photocatalytic generation of amidyl radical intermediates.

  DOI：

  10.1021/acs.orglett.7b03600
• 作为产物：
  描述：

  1,1-二(对茴香基)乙烯 在 溶剂黄146 作用下， 以 苯 为溶剂， 生成 3,3-bis(4-methoxyphenyl)-N-phenylacrylamide
  参考文献：
  名称：

  Achmatowicz,O.; Zwierzak,A., Roczniki Chemii, 1961, vol. 35, p. 525 - 532

  摘要：

  DOI：

文献信息

• Aralkanamidophenyl compounds
  申请人：AMERICAN CYANAMID COMPANY

  公开号：EP0124791A1

  公开（公告）日：1984-11-14

  This disclosure describes novel substituted aralkanamidobenzoic acids and analogs thereof. These compounds are useful pharmaceutical agents for ameliorating atherosclerosis by inhibiting the formation and development of atherosclerotic lesions in the arterial wall of mammals.

  本公开介绍了新型取代的芳香酰胺基苯甲酸及其类似物。这些化合物可抑制哺乳动物动脉壁动脉粥样硬化病变的形成和发展，是改善动脉粥样硬化的有用药物。
• Diphenyl-methane derivative, pharmaceutical composition and use
  申请人：Eisai Co., Ltd.

  公开号：EP0238973A2

  公开（公告）日：1987-09-30

  A new diphenyl-methane derivative is useful to inhibit agglomeration of blood and is defined by the formula, including a diphenylethylene derivative and a benzophenone oxime ether derivative. in which R1 and R2 each are hydrogen, hydroxyl or a lower alkoxy, U is =CXY or =N-O-W, X is hydrogen, cyano or -COR6, R6 being hydroxyl or an amino, Y is -R10-COOR3, R3 being hydrogen or a lower alkoxy, R10 being an alkylene having 1 to 3 carbon atoms, straight or branched, -CO-NR4R5, R4 and R5 each being hydrogen, a lower alkyl or a lower arylalkyl, -CH2-NHSO2-C6H5 or -C(R8)=NR7, R7 being a lower alkoxy or an aryl, R8 is -VR9, V being oxygen, sulfur or nitrogen, R9 being an alkyl or an aryl, W is -CH2-CO-CH2-C00R13, R13 being hydrogen or a lower alkyl, -CH2-C(=NOR14)-CH2-COOR15, R15 being hydrogen or a lower alkyl, R14 being a lower alkyl, -CH(CN)-(CH2)q-COOR16, R16 being hydrogen or a lower alkyl, q being an integer of 1 to 3, or -(CH2)p-Z, Z being -SH, -SCN or a monovalent group derived from a five- or six-membered ring which may be substituted by a ring having one or more sulfur atoms in the ring, p being 1 or 2. A pharmaceutical composition containing compounds of formula (XX) or their pharmaceutically acceptable salts as active ingredients, and the use of compounds of for­mula (XX) or their pharmaceutically acceptable salts in the preparation of a medicament for treatment of diseases caused by blood stream disorders are also disclosed.

  一种新的二苯基甲烷衍生物可用于抑制血液凝集，其定义式包括二苯基乙烷衍生物和二苯甲酮肟醚衍生物。 其中 R1 和 R2 各为氢、羟基或低级烷氧基，U 为 =CXY 或 =N-O-W、 X是氢、氰基或-COR6，R6是羟基或氨基，Y是-R10-COR3，R3是氢或低级烷氧基，R10是具有 1 至 3 个碳原子的直链或支链亚烷基，-CO-NR4R5、R4和R5各自为氢、低级烷基或低级芳烷基，-CH2-NHSO2-C6H5或-C(R8)=NR7，R7为低级烷氧基或芳基，R8为-VR9，V为氧、硫或氮，R9为烷基或芳基、 W 是-CH2-CO-CH2-C00R13，R13 是氢或低级烷基，-CH2-C(=NOR14)-CH2-COOR15，R15 是氢或低级烷基，R14 是低级烷基，-CH(CN)-(CH2)q-COOR16，R16 是氢或低级烷基、q为1至3的整数，或-(CH2)p-Z，Z为-SH、-SCN或由五元环或六元环衍生的单价基团，该五元环或六元环可被环中具有一个或多个硫原子的环取代，p为1或2。 本发明还公开了一种含有式（XX）化合物或其药学上可接受的盐作为活性成分的药物组合物，以及式（XX）化合物或其药学上可接受的盐在制备治疗由血流紊乱引起的疾病的药物中的用途。
• Benzophenone oxime derivatives, pharmaceutical compositions and use
  申请人：Eisai Co., Ltd.

  公开号：EP0478001A1

  公开（公告）日：1992-04-01

  A new diphenyl-methane derivative is useful to inhibit agglomeration of blood and is defined by the formula, including a diphenylethylene derivative and a benzophenone oxime ether derivative. in which R1 and R2 each are hydrogen, hydroxyl or a lower alkoxy, U is = CXY or = N-O-W, X is hydrogen, cyano or -COR6, R6 being hydroxyl or an amino, Y is -R10-COOR3, R3 being hydrogen or a lower alkoxy, R10 being an alkylene having 1 to 3 carbon atoms, straight or branched, -CO-NR4R5, R4 and R5 each being hydrogen, a lower alkyl or a lower arylalkyl, -CH2-NHS02-C6H5 or -C(R8)-= NR7, R7 being a lower alkoxy or an aryl, R8 is -VR9, V being oxygen, sulfur or nitrogen, R9 being an alkyl or an aryl, W is -CH2-CO-CH2-COOR13, R13 being hydrogen or a lower alkyl, -CH2-C(=NOR14)-CH2-COOR15, R15 being hydrogen or a lower alkyl, R14 being a lower alkyl, -CH(CN)-(CH2)q-COOR16, R16 being hydrogen or a lower alkyl, q being an integer of 1 to 3, or -(CH2)p-Z, Z being -SH, -SCN or a monovalent group derived from a five- or six-membered ring which may be substituted by a ring having one or more sulfur atoms in the ring, p being 1 or 2. A pharmaceutical composition containing compounds of formula (XX) or their pharmaceutically acceptable salts as active ingredients, and the use of compounds of formula (XX) or their pharmaceutically acceptable salts in the preparation of a medicament for treatment of diseases caused by blood stream disorders are also disclosed.

  一种新的二苯基甲烷衍生物可用于抑制血液凝集，其定义式包括一种二苯基乙烯衍生物和一种二苯甲酮肟醚衍生物。 其中 R1 和 R2 各为氢、羟基或低级烷氧基，U 为＝CXY 或＝N-O-W、 X是氢、氰基或-COR6，R6是羟基或氨基，Y是-R10-COR3，R3是氢或低级烷氧基，R10是具有 1 至 3 个碳原子的直链或支链亚烷基，-CO-NR4R5、R4和R5各自为氢、低级烷基或低级芳烷基，-CH2-NHS02-C6H5或-C(R8)-= NR7，R7为低级烷氧基或芳基，R8为-VR9，V为氧、硫或氮，R9为烷基或芳基、 W 是-CH2-CO-CH2-COOR13，R13 是氢或低级烷基，-CH2-C(=NOR14)-CH2-COOR15，R15 是氢或低级烷基，R14 是低级烷基，-CH(CN)-(CH2)q-COOR16，R16 是氢或低级烷基、q为 1 至 3 的整数，或-(CH2)p-Z，Z 为-SH、-SCN 或由五元环或六元环衍生的一价基团，该五元环或六元环可被环中具有一个或多个硫原子的环取代，p 为 1 或 2。 本发明还公开了一种含有式（XX）化合物或其药学上可接受的盐作为活性成分的药物组合物，以及式（XX）化合物或其药学上可接受的盐在制备治疗由血流紊乱引起的疾病的药物中的用途。
• The Synthesis of Some Esters and Amides of β,β-Diarylacrylic Acids
  作者：SAUL. PATAI、RAPHAEL. IKAN

  DOI：10.1021/jo01118a012

  日期：1956.12.1
• US4536346A
  申请人：——

  公开号：US4536346A

  公开（公告）日：1985-08-20